1.11B
Market cap
22.59x
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

PolyPeptide Group AG operate as a contract development and manufacturing company worldwide. It focuses on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development, and in generic products. It engages in manufacturing custom research grade peptides; and developing neoantigen peptide to support personalized cancer therapies.

Similar securities

Based on sector and market capitalization

Report issue